Recent Finacing
Recent Raise
AbCellera operates a full-stack antibody discovery platform combining high-throughput single-B-cell microfluidics, repertoire sequencing, imaging, lab automation, machine learning, and protein engineering to identify therapeutic antibodies and enable clinical manufacturing.
